Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
McFarland Clinic, PC
mi
from
Ames, IA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Midwest Cardiology Associates, P.C.
mi
from
Overland Park, KA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Midwest Cardiology Associates, P.C.
mi
from
Overland Park, KA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Central Cardiology Assoc.
mi
from
Elizabethtown, KY
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Central Cardiology Assoc.
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
New Lexington Clinic, P.S.C.
mi
from
Lexington, KY
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
New Lexington Clinic, P.S.C.
mi
from
Lexington, KY
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Va Medical Center
mi
from
Louisville, KY
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Va Medical Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Norton Cardiovascular Associates
mi
from
Louisville, KY
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Norton Cardiovascular Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Owensboro Heart & Vascular
mi
from
Owensboro, KY
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Owensboro Heart & Vascular
mi
from
Owensboro, KY
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Smith, Patel & Amkieh, Llc
mi
from
Lacombe, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Smith, Patel & Amkieh, Llc
mi
from
Lacombe, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Imperial Calcasieu Medical Group, Llp
mi
from
Lake Charles, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Imperial Calcasieu Medical Group, Llp
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardiology Center
mi
from
Marrero, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardiology Center
mi
from
Marrero, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates
mi
from
Shreveport, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates
mi
from
Shreveport, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Louisiana Heart Center
mi
from
Slidell, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Louisiana Heart Center
mi
from
Slidell, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Medical Research Inst, Inc
mi
from
Slidell, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Medical Research Inst, Inc
mi
from
Slidell, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Medical Research Institute, Inc
mi
from
Slidell, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Medical Research Institute, Inc
mi
from
Slidell, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Ventura Cardio. Cond. Med. Group, Inc.
mi
from
Ventura, LA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Ventura Cardio. Cond. Med. Group, Inc.
mi
from
Ventura, LA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Central Maine Heart & Vascular Institute
mi
from
Lewiston, ME
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Central Maine Heart & Vascular Institute
mi
from
Lewiston, ME
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Midatlantic Cardiovascular Associates
mi
from
Baltimore, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Midatlantic Cardiovascular Associates
mi
from
Baltimore, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Franklin Square Hospital
mi
from
Baltimore, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Franklin Square Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Midatlantic Cardiovascular Associates PA
mi
from
Bel Air, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Midatlantic Cardiovascular Associates PA
mi
from
Bel Air, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Specialists of Central Maryland
mi
from
Columbia, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Specialists of Central Maryland
mi
from
Columbia, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Clinical Associates Research
mi
from
Reisterstown, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Clinical Associates Research
mi
from
Reisterstown, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Midatlantic Cardiovascular Associates, P.A.
mi
from
Westminster, MD
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Midatlantic Cardiovascular Associates, P.A.
mi
from
Westminster, MD
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Burlington Medical Associates
mi
from
Billerica, MA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Burlington Medical Associates
mi
from
Billerica, MA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Lahey Clinic Medical Center
mi
from
Burlington, MA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Lahey Clinic Medical Center
mi
from
Burlington, MA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
NECCR Internal Medicine & Cardiology Associates, LLC
mi
from
Fall River, MA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
NECCR Internal Medicine & Cardiology Associates, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Pentucket Medical Associates
mi
from
Haverhill, MA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Pentucket Medical Associates
mi
from
Haverhill, MA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Charles River Medical Associates
mi
from
Natick, MA
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Charles River Medical Associates
mi
from
Natick, MA
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Great Lakes Heart Center Of Alpena
mi
from
Alpena, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Great Lakes Heart Center Of Alpena
mi
from
Alpena, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Thoracic & Cardiovascular Healthcare Foundation
mi
from
Lansing, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Thoracic & Cardiovascular Healthcare Foundation
mi
from
Lansing, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Advanced Cardiovascular Health Specialists, Pc
mi
from
Livonia, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Advanced Cardiovascular Health Specialists, Pc
mi
from
Livonia, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Michigan Heart and Vascular Specialists
mi
from
Petoskey, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Michigan Heart and Vascular Specialists
mi
from
Petoskey, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Michigan Heart, PC
mi
from
Ypsilanti, MI
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Michigan Heart, PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
North Memorial Health Care
mi
from
Robbinsdale, MN
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
North Memorial Health Care
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Olive Branch Family Medical Center
mi
from
Olive Branch, MS
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Olive Branch Family Medical Center
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Tupelo Neurology Clinic, Pa
mi
from
Tupelo, MS
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Tupelo Neurology Clinic, Pa
mi
from
Tupelo, MS
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
University of Missouri
mi
from
Columbia, MO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Truman Medical Center
mi
from
Kansas City, MO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Truman Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Lipid and Diabetes Research Center
mi
from
Kansas City, MO
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Lipid and Diabetes Research Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Internal Medical Associates Of Grand Island, P.C
mi
from
Grand Island, NE
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Internal Medical Associates Of Grand Island, P.C
mi
from
Grand Island, NE
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Nebraska Heart Institute
mi
from
Hastings, NE
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Nebraska Heart Institute
mi
from
Hastings, NE
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Va Southern Nevada Healthcare System
mi
from
Las Vegas, NV
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Va Southern Nevada Healthcare System
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Comprehensive Clinical Research
mi
from
Berlin, NJ
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Comprehensive Clinical Research
mi
from
Berlin, NJ
Click here to add this to my saved trials